Status:

COMPLETED

A Research Study to Understand and Predict the Failure of Shoulder Fracture Fixations Using Computer Simulations

Lead Sponsor:

AO Research Institute Davos

Conditions:

Proximal Humeral Fracture

Eligibility:

All Genders

50+ years

Phase:

NA

Brief Summary

Fractures of the shoulder, the so-called proximal humeral fractures, can be treated with locking plates that have shown good results in clinical practice, but complications can occur. In order to furt...

Detailed Description

Older adult patients with complex, displaced and/or unstable proximal humerus fractures treated with the PHILOS plate (DePuy Synthes Inc.) will be recruited. Detailed patient background information wi...

Eligibility Criteria

Inclusion

  • Age≥ 50 years
  • Radiologically confirmed closed fracture of the proximal humerus and treatment within 10 days after injury
  • Any displaced or unstable 3- or 4-part fracture of the proximal humerus except isolated displaced fractures of the greater or lesser tuberosity
  • Completed primary fracture treatment with a PHILOS plate with or without cement augmentation of the screws
  • Ability to understand the content of the patient information / informed consent form
  • Willingness and ability to participate in the clinical investigation including imaging, activity tracking and other FU procedures
  • Signed informed consent

Exclusion

  • Previous proximal humerus fracture on the ipsilateral side
  • Splitting fracture of the humeral head or humeral head impression fracture
  • Fibula grafting, bone block or any other non-cement augmentation of the PHILOS plate fixation
  • Any serious fracture fixation issue (serious malreduction, too long screw or screw perforating through the humeral head, broken screw or implant) that are recognized on the immediate post-OP x-rays, independently of being re-operated or not
  • Associated nerve or vessel injury
  • Any severe systemic disease: class 4 - 5 of the American Society of Anesthesiologists (ASA) physical status classification
  • Recent history of substance abuse (i.e., recreational drugs, alcohol) that would preclude reliable assessment
  • Prisoner
  • Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
  • Pregnancy
  • Pacemaker

Key Trial Info

Start Date :

August 2 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2022

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT04056351

Start Date

August 2 2019

End Date

December 31 2022

Last Update

February 1 2023

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Medical University of Innsbruck

Innsbruck, Austria

2

UZ Leuven

Leuven, Belgium